TIM
AGIO icon

Tortoise Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Tortoise Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-150
Closed -$8K – 489
2016
Q3 		$8K Hold
150
– – ﹤0.01% 333
2016
Q2 		$6K Sell
150
-450
-75% -$22.2K ﹤0.01% 368
2016
Q1 		$24K Buy
600
+325
+118% +$13.9K 0.01% 240
2015
Q4 		$18K Buy
+275
New +$18K 0.01% 268

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tortoise Investment Management's AGIO Position: Q4 2016 in Review

Tortoise Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2016, closing a stake of 150 shares — an estimated $8K sold.

Tortoise Investment Management first reported a position in AGIO in Q4 2015 and held it in 4 quarters. The position peaked at $24K in Q1 2016. 161 funds tracked by Wall St. Rank hold AGIO as of Q4 2016.

  • Tortoise Investment Management reported no remaining Agios Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Tortoise Investment Management sold 150 Agios Pharmaceuticals shares in Q4 2016, an estimated $8K.
  • Tortoise Investment Management first reported a position in Agios Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Tortoise Investment Management's Agios Pharmaceuticals position peaked at $24K in Q1 2016.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2016.

Based on Tortoise Investment Management's 13F filing for Q4 2016, filed 16 Feb 2017.